Back to Search
Start Over
MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study.
- Source :
-
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2013 Feb; Vol. 24 (2), pp. 559-66. Date of Electronic Publication: 2012 May 16. - Publication Year :
- 2013
-
Abstract
- Summary: Adequate vitamin D/calcium supplementation during osteoporosis (OP) treatments seems insufficient. This cohort study within a national claims database evaluated calcium/vitamin D co-prescription in postmenopausal women initiating an OP treatment. A high co-prescription rate was observed with three quarters of women supplemented with calcium and/or vitamin D in agreement with current recommendations.<br />Introduction: Adequate calcium/vitamin D supplementation should be taken in combination with antiresorptive drugs in OP treatment. Despite guidelines, supplementation appears to be insufficient. The objective of this study was to describe and estimate co-prescription rates of calcium/vitamin D among postmenopausal women initiating an OP treatment.<br />Methods: All women over 50 years with a first claim for a bisphosphonates, raloxifene, or strontium prescription filled between May and August 2010 were included in a retrospective cohort study. Data source was the health insurance claims database of the Rhône-Alpes area.<br />Results: Among 4,415 women, 77.0 % had co-prescription of calcium or vitamin D with initial OP treatment, of which 2,150 (49.7 %) had both calcium and vitamin D. The proportion of women with calcium and/or vitamin D (81.7 %) was significantly higher when OP treatment was a bisphosphonate compared to strontium (70.9 %) or raloxifene (67.0 %) (p < 0.05). Among women prescribed both calcium and vitamin D, 7.6 % received a bisphosphonate and vitamin D ± calcium fixed-combination pack. General practitioners prescribed two thirds of initial supplementation treatment (66.9 %). Patients were twice as likely to be prescribed supplementation when the prescriber was a rheumatologist (OR = 2; 95 % CI = 1.57-2.54).<br />Conclusion: Three quarters of women initiating OP treatment were supplemented with calcium and/or vitamin D in agreement with current recommendations. This represents a high co-prescription rate.
- Subjects :
- Administration, Oral
Age Distribution
Aged
Aged, 80 and over
Bone Density drug effects
Bone Density Conservation Agents administration & dosage
Diphosphonates administration & dosage
Diphosphonates therapeutic use
Drug Administration Schedule
Drug Prescriptions statistics & numerical data
Drug Therapy, Combination
Drug Utilization statistics & numerical data
Female
Humans
Middle Aged
Organometallic Compounds administration & dosage
Organometallic Compounds therapeutic use
Osteoporosis, Postmenopausal physiopathology
Raloxifene Hydrochloride administration & dosage
Raloxifene Hydrochloride therapeutic use
Retrospective Studies
Thiophenes administration & dosage
Thiophenes therapeutic use
Treatment Outcome
Vitamin D therapeutic use
Bone Density Conservation Agents therapeutic use
Calcium therapeutic use
Dietary Supplements
Osteoporosis, Postmenopausal drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1433-2965
- Volume :
- 24
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
- Publication Type :
- Academic Journal
- Accession number :
- 22588183
- Full Text :
- https://doi.org/10.1007/s00198-012-1999-5